Product code PCC— Neurology
Cefaly Dual
- Classification name
- Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
- Device class
- Class 2
- Regulation
- 21 CFR 882.5891
- Advisory panel
- Neurology
- Total cleared
- 18
- First cleared
- Most recent
FDA classification definition
“Used to apply an electrical current to a patient's cranium through electrodes placed on the skin.”
Market context for product code PCC
FDA has cleared devices under product code PCC between 2014 and 2026, filed by 10 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2026
- 2024
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2014
Top applicants under product code PCC
Adverse events under product code PCC
product code PCC- Other
- 1
- Total
- 1
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recent clearances under product code PCC
- K254216 — Enso for Migraine
- K242719 — ELEXIR 2.0 (ALLIVE3)
- K234029 — CEFALY Connected - OTC, CEFALY Connected - Rx
- K232749 — DOOPANG
- K233751 — Milieve (YPS-301BD)
- K230782 — TENS device-HeadaTerm 2 (Model: YF-HT2)
- K212071 — Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx
- K212106 — Relivion
- K211380 — Elexir
- K210364 — Migraine Tens Digital Pain Reliever
- K203419 — Relivion
- K201895 — Cefaly Dual
- K192773 — ALLIVE
- K172450 — TENS device-HeadaTerm, eEspress
- K173006 — Cefaly Dual
- K171446 — Cefaly Acute
- K160237 — Cefaly
- DEN120019 — CEFALY
Data sourced from openFDA. This site is unofficial and independent of the FDA.